Oncology & Cancer

Scientists design protein that prods cancer-fighting T-cells

Scientists at UW Medicine's Institute for Protein Design (IPD) in Seattle have created a new protein that mimics the action of a key immune regulatory protein, interleukin 2 (IL-2).  IL-2 is a potent anticancer drug and ...

Oncology & Cancer

The story of GARP: a potential target for cancer immunotherapy

Colorectal cancer is the third leading cause of cancer-related deaths in both men and women. Despite significant advances in therapies for this particular cancer, the five-year survival rate is 12 percent, according to the ...

Oncology & Cancer

New models of kidney cancer may drive immunotherapy research

University of North Carolina Lineberger Comprehensive Cancer Center scientists have developed preclinical laboratory models of the two most common types of kidney cancer, an advancement that may aid in the evaluation of novel ...

Oncology & Cancer

New opportunity to treat drug-resistant leukemia discovered

A study led by researchers at the Institute for Molecular Medicine Finland FIMM and Faculty of Medicine, University of Helsinki and the Helsinki University Central Hospital Comprehensive Cancer Center, in close collaboration ...

Oncology & Cancer

Researchers identify pathway that regulates angiogenesis in tumors

The formation of new blood vessels, also known as angiogenesis, is critical to the development and progression of cancer. Angiogenesis is controlled by many different protein messengers that can either stimulate or inhibit ...

Oncology & Cancer

Cancer patients face greater risks from abdominal aneurysm repair

Elective abdominal aortic aneurysm (AAA) repair in patients with a cancer diagnosis is associated with several poor postoperative outcomes according to a newly published study from researchers at the University of Missouri ...

page 3 from 20